PeerVoice Immunology & Infectious Disease Video

Thomas Dörner, MD - B-Cell Depletion for Autoimmune Rheumatic Diseases: Expert Perspectives of This Mechanistic Therapeutic Approach in Clinical Context

Nicholas J. Silvestri, MD, FAAN - From Established to Emerging Therapies: Expert Perspectives on the Latest Evidence Base on FcRn Inhibitors for gMG

Enrico Lopriore, MD, PhD - Are You Managing Pregnant Individuals? Then You Need to Know About Fetal-Neonatal Alloimmune Thrombocytopenia (FNAIT)

James F. Howard Jr, MD - Beyond FcRn and Complement Inhibitors: Why We Need Novel Treatment Options for Generalized Myasthenia Gravis

Mariana Castells, MD, PhD - Rare But Highly Significant: Best Practices in Recognizing and Diagnosing Systemic Mastocytosis

Pushpa Narayanaswami, MD, FAAN - Cutting Through the Congress Cacophony on Generalised Myasthenia Gravis: Expert Honing of the Latest Data

Onyema Ogbuagu, MD, FACP, FIDSA - Multidrug-Resistant HIV: Evaluating HIV Treatment Strategies as Options Narrow

Stephen Jolles, MRCP, FRCPath, PhD - The Many Faces of Primary Immunodeficiencies: Exploring the Plethora of Possibilities Impacting Patient-Integrated Care

Janet Pope, MD, MPH, FRCPC - Understanding the Relevance of Rheumatoid Factor Titers in Rheumatoid Arthritis: From Prognosis to Treatment

Frank Siebenhaar, PD / Vito Sabato, MD, PhD - Optimising Outcomes in Indolent Systemic Mastocytosis: A Comprehensive Review of Best Practices Across the Patient Journey

Sharon Walmsley, MD - If the Drugs Are Working, Why Switch HIV Treatment in People Who Are Virologically Suppressed?

Jane Anderson, FRCP, PhD - Health-Related Quality of Life: What Works Best for People Living With HIV?

Jan Dutz, MD, FRCPC - Clinical Updates on Targeting IL-17 in Rheumatic Diseases: Striking at the Heart of Inflammatory Processes in PsA and axSpA

Xenofon Baraliakos, MD, PhD / Philip Helliwell, MD, PhD - Can the Standard of Care Be Elevated in Spondyloarthropathies? Key Learnings From Rheumacensus Initiatives in PsA and axSpA

Milan J. Anadkat, MD - Supporting Patient-Centered Care in Generalized Pustular Psoriasis: Communications Strategies to Improve Shared Decision-Making

Mohamed El-Hussein, RN, PhD, NP / Caitlin Carreau, MN, RN(EC) - At the Forefront of Cancer Prevention: Nursing Strategies to Optimize HPV Immunization

Xavier Montalban, MD, PhD - Multiple Sclerosis and Bruton's Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?

Simon Couillard, MD, MSc - Improving Outcomes in Severe Eosinophilic Asthma: Translating Recent Evidence With Biologics Into Patient Care

George Kassianos, CBE, MD (Hons), FRCGP / Gili Regev-Yochay, MD - Current 2024 COVID-19 Vaccination Campaign: The Evidence Supporting the Call to Action

Martin van Hagen, MD, PhD - Patients Receiving Immunoglobulin Therapy: Emerging Technology for Patient-Integrated Care

Sharon Walmsley, CM, MSc, MD - Individualising ART as We Travel Through Time: Decisions Along a Life's Journey

Jürgen Rockstroh, MD - HIV and Hepatitis B: Managing Coinfections in PLWH

John K. Marshall, MD, MSc, FRCPC, AGAF, CAGF - Targeting IL-23 in Ulcerative Colitis: Can We Raise the Bar in Disease Control for Our Patients?

Antonella Castagna, MD - Designing Treatment Regimens to Suppress Multidrug-Resistant HIV: What Would You Do?

Frank Siebenhaar, MD - Indolent Isn't Insignificant: Raising Awareness of Systemic Mastocytosis and Its Symptoms

Irina Turchin, MD, FRCPC, DABD - Unraveling the Pathophysiology of Moderate-to-Severe Atopic Dermatitis: Clinical Implications for Health

Sorena Kiani, MBPhD, FRCP, FRCPath - Androgen Risk Reduction in Hereditary Angioedema: Why and How to Switch to Targeted Prophylactic Therapy?

Kurt G. Naber, MD, PhD - How Are We Tackling the Nemesis of Drug-Resistant Uropathogens?

Michael W. Nicolle, MD, FRCPC, D.Phil - Complement-Directed Therapy for Generalized Myasthenia Gravis: From Bench to Bedside

Allison Agwu, MD, ScM - Me the Clinician; Me the Mom: Why Vaccinate Children Against COVID-19?

Nizar Mahlaoui, MD, MPH, PhD - Simplifying Patient-Integrated Care for Those Requiring Immunoglobulin Therapy: Making Smart Moves with Automated and Digital Technology

C. Buddy Creech, MD, MPH - Children and the COVID Vaccine

John Papastergiou, BScPhm, PhDc - Human Papillomavirus Head and Neck Cancers: Improving Outcomes in Adults Through Vaccination

Andrew Ustianowski, MBBS, FRCP, PhD - Treating COVID-19 Early: What Patients Need to Know

Marina Berenguer, MD, PhD - Treating Hepatitis C Virus in Special Populations: Pregnant Women, Children and Adolescents

Andrew Ustianowski, MBBS, FRCP, PhD - What's Right for Me: Individualising Antiretroviral Therapy in People Living With HIV

Amitava Banerjee, MPH, DPhil, FRCP - Long COVID and Vaccination Status: What Are We Learning?

Anil K. Gupta, MD, CCFP, FCFP - Treating COVID-19 in the Outpatient Setting: Identifying Who, With What, and When?

Christine Palmay, HBArtSci, MD, CCFP, FCFP - The Case for Herpes Zoster Vaccination: Addressing Care Gaps in Immunocompromised Individuals

Jens Lundgren, MD - Applying Current European Guidance on Treating COVID-19 in Hospitalized Patients

Remo Panaccione, MD, FRCPC / Brian Bressler, MD, MS, FRCPC - It's About Time: Why We Need to Address Bowel Urgency in Patients With Ulcerative Colitis

John K. Marshall, MD, MSc, FRCPC, AGAF, CAGF - Real-World Experience With Janus Kinase Inhibitors in the Treatment of Advanced Ulcerative Colitis: What Does the Evidence Say?